Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Regulatory News
1/23/2025
CDE Issues the Guidelines for Writing Clinical-Related Information in ...
1/22/2025
CDE Issues the Technical Guideline for the Study of Storage Period for...
1/16/2025
CDE Issues the Technical Guidelines for Clinical Risk Management Plans...
1/15/2025
U.S. Tightens Export Controls on Biotech Equipment Over AI and Securit...
1/13/2025
NMPA Announces Package Insert Revision of Human Albumin Injection
1/12/2025
US Officials Push for Stricter Regulations on Biotech Exports to Preve...
1/11/2025
CDE Issues the Technical Guidelines for In Vitro Comparative Studies o...
1/11/2025
CDE Issues the Technical Guidelines for Clinical Development of New Dr...
1/11/2025
CDE Issues the Technical Guidelines for Clinical Trials of Anti-Monkey...
1/11/2025
CDE Issues the Technical Guidelines for Nonclinical Efficacy Studies o...
1/11/2025
CDE Issues the List of Reference Formulations for GQCE Studies (89th B...
1/11/2025
NMPA Holds the 2025 National Drug Supervision Work Conference
1/6/2025
CDE Issues the List of Reference Formulations for GQCE Studies (88th B...
1/6/2025
NMPA Withdraws Registration of All Belladonna Sulfobenzide Tablets
1/6/2025
State Council Issues New Policy Document on Deepens Reform to Strength...
1/3/2025
CDE Issues the Technical Guidelines for Clinical Pharmacology Research...
1/3/2025
CDE Publicizes the List of Reference Formulations for GQCE Studies (90...
1/3/2025
NMPA Issues Annexes for Pharmaceutical Excipients and Packaging Materi...
1/3/2025
NMPA Withdraws Registration for Belladonna Sulfabenzamide Tablets
1/3/2025
China Punishes 40,000 in Medical Corruption Crackdown, Targeting Over ...
12/30/2024
NMPA Announces Package Insert Revision of Potassium Bismuth Citrate Gr...
12/27/2024
CDE Issues the List of Reference Formulations for GQCE Studies (87th B...
12/25/2024
China NMPA Accepts NDA for ARS Pharma's Epinephrine Nasal Spray
12/25/2024
NMPA Announces Package Insert Revision of Human Tetanus Immunoglobulin...
12/24/2024
CDE Seeks Comments on the Supplementary List of External Experts for t...
12/22/2024
Deputy NMPA Commissioner Attends GHWP Annual Meeting
12/20/2024
CDE Issues the List of Reference Formulations for GQCE Studies (86th B...
12/16/2024
NMPA Announces OTC Switch of Ketoprofen Patch
12/16/2024
CDE Seeks Comments on the Draft Technical Guidelines for Pharmaceutica...
12/16/2024
CDE Seeks Comments on the Draft Requirements for Writing Module 2.3 Ph...
Page:
2
/
8
Total number of articles:
224
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit